-+ 0.00%
-+ 0.00%
-+ 0.00%

*MetaVia Dosed First Patient in 8-Week 48 Mg MAD Cohort of Phase 1 Trial to Further Explore Non-Titrated Maximum Tolerated Dose of DA-1726 for Obesity >MTVA

Dow Jones·11/06/2025 13:41:00

Please log in to view news